Cycle Pharmaceuticals INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$319Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
3,266clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Sajazir $56K associated (2023-2025)
- Tascenso Odt $49K associated (2023-2025)
- Bafiertam $28K associated (2023-2025)
- Phyrago $21K associated (2023-2025)
- Venxxiva $12K associated (2023-2025)
- Ormalvi $9,917 associated (2023-2025)
- Javygtor $5,034 associated (2023-2025)
- Cromolyn Sodium $4,510 associated (2023-2025)
- Tiopronin $3,228 associated (2023-2025)
- Nityr $637 associated (2023-2025)
- Fuzyro (Development) $230 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Stephen Krieger | New York, NY | Neurology (Psychiatry & Neurology) | $14,561.08 |
| Benjamin Greenberg | Dallas, TX | Neurology (Psychiatry & Neurology) | $12,470.00 |
| Jonathan Santoro | Palo Alto, CA | Neurology With Special Qualifications In Child Neurology | $8,695.50 |
| Marc Riedl | San Diego, CA | Allergy & Immunology | $8,198.14 |
| Jeffrey Chinsky | Baltimore, MD | Pediatrics | $6,498.95 |
| Daniel Bandari | Newport Beach, CA | Neurology (Psychiatry & Neurology) | $5,445.18 |
| Douglas Jones | Layton, UT | Allergy | $4,007.36 |
| Hagop Kantarjian | Houston, TX | Medical Oncology | $3,500.00 |
| John Scagnelli | Raleigh, NC | Neurology (Psychiatry & Neurology) | $3,173.62 |
| Jeffrey Rumbyrt | Lakewood, CO | Allergy & Immunology | $3,119.95 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.